Actinium Pharmaceuticals Inc., of New York, appointed Sergio A. Giralt, Hillard M. Lazarus, Peter A. McSweeney and John M. Pagel to its news scientific advisory board.

Alexza Pharmaceuticals Inc., of Mountain View, Calif., named Edwin S. Kamemoto senior vice president, regulatory affairs.

Alk-Abello A/S, of Copenhagen, appointed Helle Skov executive vice president, product supply.

Applied Genetic Technologies Corp., of Alachua, Fla., named Matthew Feinsod product development officer, and added David R. Guyer and Ivana Magovcevic-Liebisch to its board.

Astellas Pharma US Inc., of Northbrook, Ill., part of Astellas Pharma Inc., of Tokyo, appointed Marty Golden vice president, government affairs. Golden will lead federal government affairs, state government affairs, therapeutic area government strategy and corporate government strategy for Astellas in the Americas.